4LSC2520 [13C6]-Vemurafenib

Catalog Number: 4LSC2520
CAS #: N/A
Related CAS #: 918504-65-1 (unlabeled)
Name: [13C6]-Vemurafenib; N-(3-(5-(4-chlorophenyl-1,2,3,4,5,6-13C6)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide

Vemurafenib is a B-Raf enzyme inhibitor developed for the treatment of late-stage melanoma.

Stable isotope labeled Vemurafenib is intended for use as an internal standard for the quantification of Vemurafenib by LC or GC-mass spectrometry.

If the number, nature and/or location of stable isotope label atoms (D, 15N, 13C) in this molecule don’t fit with your application, don’t hesitate to contact us to discuss your specific needs.

Keywords:

Stable isotope labeled active pharmaceutical ingredient (API), stable isotope dilution analysis, internal standard, stable isotope labeled standard (SIL), therapeutic drug monitoring (TDM), quantitative bioanalytical method validation, clinical diagnosis, LC/MS method validation, quantitative proteomics, selective reaction monitoring (SRM), multiple reaction monitoring (MRM), peptide based quantitative proteomics, custom stable isotope labeled (SIL) peptide, diagnostic breath test, clinical chemistry, diagnostic tools & biomarkers.

  • Molecular Formula: C1713C6H18ClF2N3O3S
  • Molecular Weight: 495.88 g/mol
  • Specification:
    Minimum chemical purity: 95.0 %
    Minimum Isotopic Enrichment: 13C ≥99 %
  • Solubility: Methanol (MeOH), Dimethylsulfoxide (DMSO),
  • HS Code: 284590

N/A